Osborne William H 4

What Happened

• William H. Osborne, a non-management director of Quaker Chemical (KWR), had restricted stock units (RSUs) convert into common stock following vesting on May 31, 2026 and was granted a new RSU award. Transactions reported: conversion/acquisition of 1,198 and 18 shares (derivative conversions listed as N/A), a disposition of 1,198 derivative shares at $0.00, and a new grant of 975 RSUs on June 1, 2026 (975 shares @ $0.00). No cash purchase or sale proceeds are reported — these were RSU conversions/awards rather than open-market trades.

Key Details

• Transaction dates: conversions/settlement on 2026-05-31; new grant dated 2026-06-01. Filing date: 2026-06-02 (reporting period 2026-05-31).
• Prices/values: conversions listed at N/A; one disposition shown at $0.00 (derivative); new grant 975 RSUs @ $0.00. No cash proceeds reported.
• Shares owned after transaction: not specified in the provided filing excerpt.
• Relevant footnotes from the filing:
  • RSUs convert one-for-one into common shares (F1).
  • Some shares reflect settlement of dividend equivalent rights tied to RSU vesting (F2).
  • The RSUs that vested were granted on June 1, 2025 and vested 100% on May 31, 2026 (F3).
  • The 975-RSU grant is a time-based director award under the long-term incentive plan; these RSUs vest 100% on May 31, 2027 and accrue dividend equivalents (F4, F5).
• Timeliness: filing appears timely (filed 2026-06-02 for transactions through 2026-05-31).

Context

• These transactions are vesting/conversion and grant events for RSUs (derivative instruments), not market purchases or voluntary sales. The reported $0.00 disposition typically reflects shares surrendered/withheld as part of conversion/settlement processes (e.g., taxation or dividend-equivalent settlement) rather than an open-market sale.
• For retail investors, award conversions and new RSU grants are standard compensation actions by the company and do not by themselves indicate trading intent by the director.